View printer-friendly version

Mayor Virg Bernero Leads Ribbon Cutting of Emergent BioSolutions’ New Administration Building Representing Another Step in Its Lansing Campus Expansion

ROCKVILLE, Md.–(BUSINESS WIRE)–Jun. 17, 2013– Lansing, Michigan Mayor Virg Bernero and senior executives from Emergent BioSolutions Inc. (NYSE:EBS) today held a ribbon cutting ceremony to commemorate the formal opening of a new administration building at Emergent’s Michigan campus. The 32,000 sq. ft. building marks the new entrance to the company’s 12.5-acre site and symbolizes Emergent’s commitment to its employees and to growth in the community.

“The addition of Building 63 represents our continued commitment to our role as premier supplier of medical countermeasures as well as our steady growth and investment in the Lansing community,” said Fuad El-Hibri, executive chairman of the board, Emergent BioSolutions. “Emergent has achieved many milestones since its founding in 1998, each unique and a source of pride. What is truly most rewarding, however, is to witness the dedication of our employees to our corporate mission – to protect life.”

Emergent employs over 850 employees across the globe, with more than 450 employees located in Lansing, where the company was founded 15 years ago. The new building consists of office space, conference rooms, collaboration spaces, and workout and dining facilities. The company continues to make investments at the Lansing site, which have included a new manufacturing building in 2006, a new testing facility in 2012 and now a new administration building. Future expansion potentially includes a new warehouse facility as well as a science building.

“The City of Lansing recognizes Emergent’s positive contribution to the community,” said Mayor Bernero. “Emergent helps Michigan as a whole maintain its status as a leader in the manufacturing sector and brings high paid, high skilled jobs to the area. I am proud of the work that is being done here in Lansing that helps keep Americans healthy and safe.”

About Emergent BioSolutions

Emergent BioSolutions is a specialty pharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information may be found at www.emergentbiosolutions.com. Follow us on twitter: @emergentbiosolu.

Source: Emergent BioSolutions Inc.

Emergent BioSolutions Inc.
Investors Contact:
Robert G. Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media Contact:
Tracey Schmitt
Vice President, Corporate Communications
301-795-1800
SchmittT@ebsi.com

This website uses cookies. This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to the Privacy Notice and Terms of Use.